0000899243-16-026413.txt : 20160805
0000899243-16-026413.hdr.sgml : 20160805
20160805160547
ACCESSION NUMBER: 0000899243-16-026413
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150807
FILED AS OF DATE: 20160805
DATE AS OF CHANGE: 20160805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prothena Corp plc
CENTRAL INDEX KEY: 0001559053
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 1
BUSINESS PHONE: 650-615-2119
MAIL ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: DUBLIN 1
FORMER COMPANY:
FORMER CONFORMED NAME: Neotope Corp Ltd
DATE OF NAME CHANGE: 20120926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENNEY CHRISTOPHER S
CENTRAL INDEX KEY: 0001242880
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35676
FILM NUMBER: 161811181
MAIL ADDRESS:
STREET 1: 10505 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2015-08-07
2015-08-07
0
0001559053
Prothena Corp plc
PRTA
0001242880
HENNEY CHRISTOPHER S
C/O PROTHENA BIOSCIENCES INC
650 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Ordinary Shares, par value $0.01 per share
2015-08-07
4
M
0
10000
6.65
A
10000
D
Ordinary Shares, par value $0.01 per share
2015-08-07
4
S
0
4400
62.3356
D
5600
D
Ordinary Shares, par value $0.01 per share
2015-08-07
4
S
0
4560
63.2523
D
1040
D
Ordinary Shares, par value $0.01 per share
2015-08-07
4
S
0
1040
64.0301
D
0
D
Stock Option (right to buy)
6.65
2015-08-07
4
M
0
10000
0.00
D
2023-03-18
Ordinary Shares
10000
40000
D
The transaction was executed in multiple trades in prices ranging from $61.785 to $62.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The transaction was executed in multiple trades in prices ranging from $62.80 to $63.785, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The transaction was executed in multiple trades in prices ranging from $63.84 to $64.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option are fully vested and exercisable as of the date hereof.
In the original Form 4 filed on August 7, 2015, due to an administrative error, the purchase price in column four of row one of Table I was incorrectly listed as $6.41, rather than the correct purchase price of $6.65. This amendment is filed to correct the Form 4 to report the acquisition price of $6.65 per share under the reported transaction.
/s/ A.W. Homan, as Attorney-in-Fact for Christopher S. Henney
2016-08-05